Meeting Report: Third ESWI Science Policy Interface Roundtable, Bucharest (22 October 2026)
Consistent messaging, collaboration and a clear way forward needed to strengthen prevention in Romania
|
Shaping the Future of Respiratory Virus Research
Understanding the Transmission of Respiratory Viruses
How do we detect infections that might otherwise go unnoticed? And what can we learn about immunity where these viruses enter the body? These key questions, among many others, are expertly explored and explained by Dr Nicole Tsang and Dr Kevin Selva.
Summary report OECD/EUPHA - Long COVID Policy Dialogue
This publication is part of the “Supporting long COVID patients: insights and action initiative (2024-2026)” of the European Commission.
Beyond childhood: why lifelong vaccination is a frontline defence against chronic disease
Guest article by the World Federation of Public Health Associations (WFPHA)
Effectiveness of nirsevimab immunisation on invasive pneumococcal disease in children nationwide in France: an observational cohort study
These findings suggest an additional benefit of nirsevimab implementation beyond RSV disease prevention, but further studies are needed.
Recombinant Influenza Vaccine and Influenza Outbreaks in US Nursing Homes: Results From a Pragmatic Cluster-Randomized Clinical Trial
These findings suggest that recombinant influenza vaccines may provide clinically meaningful facility-level benefits in long-term care settings during seasons with substantial influenza circulation.
High-dose vs standard-dose influenza vaccine in heart failure: the FLUNITY-HD pooled analysis
The results of prior randomized trials investigating the potential role of influenza vaccination in preventing severe clinical events in various HF populations have been mixed.
Immunogenicity and safety of an MF59-adjuvanted cell-derived higher-dose quadrivalent influenza vaccine (aQIVc) in adults aged 50 years or older: a phase 3 randomised controlled trial
In adults aged 50 years or older, aQIVc was non-inferior and superior to aQIV for all four influenza strains and non-inferiority criteria for aQIVc versus QIVr were met for A/H1N1 and both B strains, but not A/H3N2.